Evidence map›Paper›PMID 37241036›Full record

ArticleJournal of personalized medicine2023

Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre.

Baijaeek Sain, Arnab Gupta, Aruni Ghose, Sudip Halder, Vishal Mukherjee, Samir Bhattacharya, Radha Raman Mondal, Aditya Narayan Sen, Bijan Saha, Shravasti Roy and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Baijaeek SainDepartment of Trauma & Orthopaedics, Imperial College London Healthcare NHS Trust, London W2 1NY, UK.ORCID 0000-0002-5634-5265
Arnab GuptaDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.
Aruni GhoseDepartment of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London SG1 4AB, UK.ORCID 0000-0001-8332-8033
Sudip HalderDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.ORCID 0000-0001-9849-638X
Vishal MukherjeeDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.
Samir BhattacharyaDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.
Radha Raman MondalDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.ORCID 0000-0003-3386-0341
Aditya Narayan SenDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.
Bijan SahaDepartment of Surgical Oncology, Saroj Gupta Cancer Center and Research Institute, Kolkata 700063, India.
Shravasti RoyDepartment of Pathology, Saroj Gupta Cancer Centre and Research Institute, Kolkata 700001, India.
Stergios BoussiosDepartment of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, UK.ORCID 0000-0002-2512-6131
Saroj Gupta Cancer Centre & Research Institute · INImperial College Healthcare NHS Trust · GBMedway School of Pharmacy · GBSt Bartholomew's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhyllodes tumors (PTs) of the breast are rare fibroepithelial tumors that are generally more prone to recurrence. AIMS AND

objectivesThis study aimed to assess the clinicopathological features, diagnostic modalities, and therapeutic interventions, along with their respective outcomes, to identify the factors associated with a recurrence of PTs of the breast. METHODOLOGY: A retrospective cohort and observational study was conducted, which entailed analyzing the clinicopathological data of patients who were previously diagnosed or presented with PTs of the breast between 1996 and 2021. Data included the total number of patients diagnosed with PTs of the breast and their ages, tumor grade on initial biopsy, tumor location (left or right breast), tumor size, therapeutic interventions carried out (including surgery-either mastectomy or lumpectomy-and adjuvant radiotherapy), final tumor grade, recurrence status, type of recurrence, and time to recurrence.

resultsWe analyzed data on a total of 87 patients who were pathologically proven to have PTs, and 46 patients (52.87%) were found to have recurrences. All patients were female, with a mean age at diagnosis of 39 years (range 15-70). Patients aged <40 years had the highest incidence of recurrence, with a rate of 54.35% (n = 25/46), followed by patients aged >40 years, with a rate of recurrence of 45.65% (

conclusionPatients who received adjuvant radiotherapy (RT) had a minimal recurrence of PTs. Patients who were found to have a malignant biopsy on initial diagnosis (triple assessment) had a higher incidence of PTs and were more prone to SR than LR. Surgery was a determining factor in the increased rate of LR, with lumpectomy associated with a higher incidence of LR than mastectomy.

Indexed as

breastlocalmetastasisphyllodesrecurrencesurgerysystemic

Identifiers

PMID37241036
PMCPMC10221551
OpenAlexW4377293528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.